Beigene Ltd
HKEX:6160
Beigene Ltd
HKEX:6160
Price:
190.5
HKD
3.03%
Market Closed
Market Cap:
HK$259.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Beigene Ltd
HKEX:6160
|
CN |
|
POCO Holding Co Ltd
SZSE:300811
|
CN |
|
Brightcove Inc
NASDAQ:BCOV
|
US |
|
Elanor Investors Group
ASX:ENN
|
AU |
|
Alumis Inc
NASDAQ:ALMS
|
US |
|
GRN Holding Corp
OTC:GRNF
|
US |
|
MFA Financial Inc
NYSE:MFA
|
US |
|
R
|
Ral Yatirim Holding AS
IST:RALYH.E
|
TR |
|
Allied Minds PLC
LSE:ALM
|
UK |
|
Interroll Holding AG
SIX:INRN
|
CH |
|
Volkswagen AG
F:VOWB
|
DE |
|
Cobalt Blue Holdings Ltd
ASX:COB
|
AU |
|
H
|
Hor Kew Corporation Ltd
SGX:BBP
|
SG |
|
STMicroelectronics NV
OTC:STMEF
|
CH |
|
E
|
Eprcomunicazione SpA Societa Benefit
MIL:EPRB
|
IT |
|
New Peoples Bankshares Inc
OTC:NWPP
|
US |
|
E-L Financial Corp Ltd
TSX:ELF
|
CA |
|
Murphy Oil Corp
NYSE:MUR
|
US |
|
Brundage-Bone Concrete Pumping Holdings Inc
NASDAQ:BBCP
|
US |
|
Orion Oyj
OTC:ORINF
|
FI |
Multiples-Based Value
The
Multiples-Based Value for
Beigene Ltd (6160)
under the Base Case is
hidden
HKD.
Compared with the current market price of 190.5 HKD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Beigene Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Beigene Ltd Competitors
Beigene Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Beigene Ltd
HKEX:6160
|
274B HKD | 6.8 | -1 575.4 | 214.3 | 214.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88.1 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.2 | 28 | 21 | 21.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.5 | 17.6 | 13 | 14.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44B EUR | 12.4 | 39.8 | 43.2 | 44.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
